title: [Studies on the new anticancer preparation, 5-fluorouracil-polyglycolic acid-composite and its therapeutic evaluation].
abstract: The purpose of these studies was to characterize the effect of the new anticancer preparation, 5-fluorouracil-polyglycolic acid-composite (F-PGA needle), on experimental tumors and in patients with solid tumors. The formative composite in a F-PGA needle was found to easily dissociate in physiologic saline resulting in the release of 5-fluorouracil (5-FU). The aspect of 5-FU release was observed to be relative to 5-FU content in the needle, but not to the length of the needle. When a F-PGA needle of 10mm in length and 30% in 5-FU content was subcutaneously or intrahepatically implanted in healthy rats, the release of 5-FU was maintained for 9 days in each case. Pathophysiologic examination of the liver following the implantation of a F-PGA needle revealed an increase in severe necrosis and/or degeneration and infiltration of small-round cells with the increase in release of 5-FU. Implantation of F-PGA needles into tumor mass of AH 130-bearing rats resulted in an increased 5-FU level in tumor tissue reaching the maximum level of 16.00 +/- 1.98 micrograms/g after 24 hours, and in a marked inhibition of the tumor growth indicating 2.4% of T/C (tested/controlled) at 10 days after implantation of the needle. A study of the F-PGA needle was made for 10 patients with terminal carcinomas and in 5 of these were verifiable. Of these 5 patients, shrinkage of tumors or improvement of symptoms was observed in 3 cases. From these results, the F-PGA needle is promising in the treatment of unresectable cancer as a long-acting chemotherapy.
mesh_terms: D000368:Aged; D000818:Animals; D003692:Delayed-Action Preparations; D004343:Drug Implants; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009339:Needles; D011100:Polyglycolic Acid; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D003692:Delayed-Action Preparations; D004343:Drug Implants; D011100:Polyglycolic Acid; D005472:Fluorouracil